383 related articles for article (PubMed ID: 34299378)
1. Regulation of VEGFR Signalling in Lymphatic Vascular Development and Disease: An Update.
Secker GA; Harvey NL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299378
[TBL] [Abstract][Full Text] [Related]
2. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
Secker GA; Harvey NL
Dev Dyn; 2015 Mar; 244(3):323-31. PubMed ID: 25399804
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
[TBL] [Abstract][Full Text] [Related]
4. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.
Wirzenius M; Tammela T; Uutela M; He Y; Odorisio T; Zambruno G; Nagy JA; Dvorak HF; Ylä-Herttuala S; Shibuya M; Alitalo K
J Exp Med; 2007 Jun; 204(6):1431-40. PubMed ID: 17535974
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor signaling in development and disease.
Karaman S; Leppänen VM; Alitalo K
Development; 2018 Jul; 145(14):. PubMed ID: 30030240
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
7. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
9. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
10. Development and hormonal regulation of the ovarian lymphatic vasculature.
Brown HM; Robker RL; Russell DL
Endocrinology; 2010 Nov; 151(11):5446-55. PubMed ID: 20843998
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
13. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
14. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.
Haiko P; Makinen T; Keskitalo S; Taipale J; Karkkainen MJ; Baldwin ME; Stacker SA; Achen MG; Alitalo K
Mol Cell Biol; 2008 Aug; 28(15):4843-50. PubMed ID: 18519586
[TBL] [Abstract][Full Text] [Related]
15. Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development.
Bower NI; Vogrin AJ; Le Guen L; Chen H; Stacker SA; Achen MG; Hogan BM
Development; 2017 Feb; 144(3):507-518. PubMed ID: 28087639
[TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
Karpanen T; Wirzenius M; Mäkinen T; Veikkola T; Haisma HJ; Achen MG; Stacker SA; Pytowski B; Ylä-Herttuala S; Alitalo K
Am J Pathol; 2006 Aug; 169(2):708-18. PubMed ID: 16877368
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
18. Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth.
Urner S; Planas-Paz L; Hilger LS; Henning C; Branopolski A; Kelly-Goss M; Stanczuk L; Pitter B; Montanez E; Peirce SM; Mäkinen T; Lammert E
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30518533
[TBL] [Abstract][Full Text] [Related]
19. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M; Bry M; Tammela T; Alitalo K
Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
[TBL] [Abstract][Full Text] [Related]
20. ETS transcription factor Etsrp / Etv2 is required for lymphangiogenesis and directly regulates vegfr3 / flt4 expression.
Davis JA; Koenig AL; Lubert A; Chestnut B; Liu F; Palencia Desai S; Winkler T; Pociute K; Choi K; Sumanas S
Dev Biol; 2018 Aug; 440(1):40-52. PubMed ID: 29753018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
